Filter Results:
(309)
Show Results For
- All HBS Web
(309)
- News (86)
- Research (185)
- Events (1)
- Multimedia (3)
- Faculty Publications (46)
Show Results For
- All HBS Web
(309)
- News (86)
- Research (185)
- Events (1)
- Multimedia (3)
- Faculty Publications (46)
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
Cambridge, Massachusetts, and you will likely be administered beta blockers, a class of drug that's generally recommended after a heart attack. The rate at which that drug is... View Details
- 01 Jun 2001
- News
Stephen M. Moret: A Campaign for Positive Change
low-cost HIV/AIDS drugs to Malawi. “I’m the guy who still can’t believe I got to go to school here.” After traveling around the world this fall, Moret will take a position in McKinsey’s Washington, D.C., office, where he hopes to spend... View Details
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created a scalable, acquisition-based... View Details
- 09 Aug 2016
- First Look
August 9, 2016
spending in the United States, accounting for less than 1% of prescriptions filled but nearly 28% of drug spending. Whereas traditional (chemically synthesized, "small-molecule") drugs have... View Details
Keywords: Sean Silverthorne
- 15 Dec 2024
- News
After Ozempic
affiliate in Plainsboro, New Jersey. That all changed when its breakthrough drug for type 2 diabetes, Ozempic, hit the market in 2018. By some biochemical mystery, it also turned out to be a powerful tool for weight loss—which led to the... View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
wants to understand the barriers to effecting change on global issues such as health care." Under Ray Gilmartin's leadership, Merck has launched an unprecedented number of new drugs and forged partnerships with the public and nonprofit... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
drug and the FDA says it is safe and effective and doctors prescribe it, insurance generally will pay for it. But everyone is getting fed up with that approach—the ‘Pharma bro’ Martin Shkreli did not... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
cells in cancer patients) generated more than $2 billion in sales last year. Millennium Pharmaceuticals: Alan Crane (photo: Shelly R. Harrison) As the ability to analyze a patient's genetic material is developed, however, many believe... View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
drugs (chemically-synthesized, “small-molecule” drugs) face price competition from generic drugs after patent expiration, biosimilars—biologic View Details
Keywords: Sean Silverthorne
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the disease in 2004, just weeks... View Details
Keywords: Margie Kelley
- 01 Dec 2013
- News
To Market, to Market
and other tasks necessary to determine the best route for product commercialization. "By increasing the collaborative efforts between HBS and Harvard's scientific community, we will empower the next generation of life science... View Details
- 01 Sep 2017
- News
Ink: Miami’s Dark Neon Era, the Language of Success, and Getting Psyched Up
generations of Cuban refugees fought for control of the drug trade in Miami.” Classic Havana Nocturne How the Mob Owned Cuba and Then Lost It to the Revolution by T.J. English “All these mobsters are dead,... View Details
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
- 01 Dec 2003
- News
Alumni Luminaries Discuss Careers, Values with HBS Students
leading-edge R&D, Novartis considers community outreach an essential part of its mission. It offers some drugs at a discount or free to needy patients; a new malaria therapy will be available at cost. Greylock, one of the country’s most... View Details
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's... View Details
Keywords: Julia Hanna
- Student-Profile
A Jay Holmgren
business, health policy, and medicine,” he says. “I’ve been able to connect with people from all corners of the University working in healthcare and related fields.” Research A Jay has worked closely with Dr. David Bates, chief of general... View Details
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced into the general population,... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
general purpose (e.g., quality management) to highly market specific (e.g., knowing how to manufacture an airplane wing). To illustrate the potential of the framework to shed new light on traditional strategy questions, the article... View Details
Keywords: Sean Silverthorne
- Web
Market Perspectives - Course Catalog
cases explore concrete situations that highlight the challenges and tradeoffs of decision-makers. Issues explored include: education, urban development, illegal drugs, rent control, housing, drug pricing, racial references, corporate... View Details
- 02 Feb 2021
- Blog Post
Finding My Focus in Health care Amidst a Global Pandemic
enough to find myself at Flatiron Health, a health-tech company focused on oncology. For the next three years, I worked on building strategic partnerships between Flatiron and biopharma companies developing the next generation of cancer... View Details